Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Net Present Value Impact of FDA's Phase 3 Waivers on Monoclonal Antibody Biosimilar Development.

Biologics : targets & therapy·2026
Same author

Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value.

Biologics : targets & therapy·2025
Same author

Enzymatic Routes for Chiral Amine Synthesis: Protein Engineering and Process Optimization.

Biologics : targets & therapy·2024
查看所有相关文章

相关实验视频

Updated: May 13, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.5K

推进单克隆抗体制造:流程优化,成本降低策略和新兴技术

Ranjit Ranbhor1

  • 1Pergament & Cepeda LLC, Florham Park, NJ, 07932, USA.

Biologics : targets & therapy
|April 14, 2025
PubMed
概括

单克隆抗体 (mAb) 制造的进步,如连续处理和先进分析,提供了显著的成本节约和效率提升. 优化这些技术是满足全球对mAb疗法的需求的关键.

科学领域:

  • 生物技术和生物制药制造业 生物技术和生物制药制造业
  • 过程工程和优化过程工程和优化

背景情况:

  • 单克隆抗体 (mAb) 治疗方法至关重要,需要高效和成本效益的制造工艺.
  • 目前的mAb生产面临着可扩展性,成本降低和流程优化方面的挑战.

研究的目的:

  • 审查最近在单克隆抗体 (mAb) 制造方面的进展.
  • 评估流程优化和降低成本的策略.
  • 评估新兴技术对mAb生产效率的影响.

主要方法:

  • 对mAb制造工艺的综合文献分析.
  • 检查传统的批量,连续和混合加工系统.
  • 评估成本优化技术和新兴技术,如机器学习.

主要成果:

  • 连续加工可以为特定生产规模节省高达35%的成本.
  • 混合设施实现更早的利能力 (2-2,5年更早).
  • 先进的媒体优化和分析显著改善了mAb标题和过程控制.

结论:

  • mAb制造业的发展为提高效率和降低成本提供了机会.
关键词:
先进的分析分析技术.生物制造 生物制造 生物制造生物类似药物生物类似药物连续加工是连续加工的过程.降低成本 降低成本机器学习是机器学习.过程优化优化过程优化

更多相关视频

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

10.9K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.3K

相关实验视频

Last Updated: May 13, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.5K
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

10.9K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.3K
  • 规模依赖的策略和新兴技术对于优化至关重要.
  • 持续处理和分析领域的未来发展对于满足全球需求至关重要.